154 related articles for article (PubMed ID: 20683153)
1. Conflicting views on the molecular structure of the cancer antigen CA125/MUC16.
Bouanene H; Miled A
Dis Markers; 2010; 28(6):385-94. PubMed ID: 20683153
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.
White B; Patterson M; Karnwal S; Brooks CL
Proteins; 2022 May; 90(5):1210-1218. PubMed ID: 35037700
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
Rao TD; Tian H; Ma X; Yan X; Thapi S; Schultz N; Rosales N; Monette S; Wang A; Hyman DM; Levine DA; Solit D; Spriggs DR
PLoS One; 2015; 10(5):e0126633. PubMed ID: 25965947
[TBL] [Abstract][Full Text] [Related]
4. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
Zhang M; Cheng S; Jin Y; Zhao Y; Wang Y
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188503. PubMed ID: 33421585
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16).
Berman ZT; Moore LJ; Knudson KE; Whelan RJ
Tumour Biol; 2010 Oct; 31(5):495-502. PubMed ID: 20563897
[TBL] [Abstract][Full Text] [Related]
6. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C
Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the molecular nature of ovarian cancer biomarker CA125.
Weiland F; Martin K; Oehler MK; Hoffmann P
Int J Mol Sci; 2012; 13(8):10568-10582. PubMed ID: 22949880
[TBL] [Abstract][Full Text] [Related]
9. MUC16/CA125 in the context of modular proteins with an annotated role in adhesion-related processes: in silico analysis.
Jankovic M; Mitic N
Int J Mol Sci; 2012; 13(8):10387-10400. PubMed ID: 22949868
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
Yin BW; Dnistrian A; Lloyd KO
Int J Cancer; 2002 Apr; 98(5):737-40. PubMed ID: 11920644
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
Aithal A; Junker WM; Kshirsagar P; Das S; Kaur S; Orzechowski C; Gautam SK; Jahan R; Sheinin YM; Lakshmanan I; Ponnusamy MP; Batra SK; Jain M
PLoS One; 2018; 13(4):e0193907. PubMed ID: 29708979
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and morphological differences between CA125 isolated from healthy women and patients with epithelial ovarian cancer from Tunisian population.
Bouanène H; Saibi W; Mokni M; Sriha B; Ben Fatma L; Ben Limem H; Ben Ahmed S; Gargouri A; Miled A
Pathol Oncol Res; 2012 Apr; 18(2):325-30. PubMed ID: 21901274
[TBL] [Abstract][Full Text] [Related]
13. [Tumor Marker CA125: biochemical and molecular properties].
Bouanène H; Miled A
Bull Cancer; 2009 May; 96(5):597-601. PubMed ID: 19435686
[TBL] [Abstract][Full Text] [Related]
14. A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
Wang CW; Weaver SD; Boonpattrawong N; Schuster-Little N; Patankar M; Whelan RJ
Cancer Res Commun; 2024 Jan; 4(1):253-263. PubMed ID: 38197671
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125.
Kui Wong N; Easton RL; Panico M; Sutton-Smith M; Morrison JC; Lattanzio FA; Morris HR; Clark GF; Dell A; Patankar MS
J Biol Chem; 2003 Aug; 278(31):28619-34. PubMed ID: 12734200
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.
Morgado M; Sutton MN; Simmons M; Warren CR; Lu Z; Constantinou PE; Liu J; Francis LL; Conlan RS; Bast RC; Carson DD
Oncotarget; 2016 Mar; 7(12):14871-84. PubMed ID: 26918940
[TBL] [Abstract][Full Text] [Related]
17. [MUC16: The Novel Target for Tumor Therapy].
Gao R; Lou N; Han X; Shi Y
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):452-459. PubMed ID: 35899441
[TBL] [Abstract][Full Text] [Related]
18. Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway.
Huo Q; Xu C; Shao Y; Yu Q; Huang L; Liu Y; Bao H
Int J Biol Sci; 2021; 17(2):574-588. PubMed ID: 33613114
[No Abstract] [Full Text] [Related]
19. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.
Rump A; Morikawa Y; Tanaka M; Minami S; Umesaki N; Takeuchi M; Miyajima A
J Biol Chem; 2004 Mar; 279(10):9190-8. PubMed ID: 14676194
[TBL] [Abstract][Full Text] [Related]
20. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]